T-cell engagers, especially BiTEs, show promise in treating solid tumors by targeting tumor-associated antigens and redirecting T-cell activity. Tarlatamab, targeting DLL3 in SCLC, demonstrated ...

U of A Comprehensive Cancer Center Director Dr. Dan Theodorescu plans to study loss of Y chromosome biology and investigate ...

The Incucyte ® Cytotoxicity Assay uses the Incucyte ® Cytotox Dyes and the Incucyte ® Live-Cell Analysis System to evaluate ...

For the first time, researchers have successfully fabricated and characterized a fully functional mirror-image nanopore—a ...

Learn about pet bloodwork, the tests involved, and how to interpret results to ensure your furry friend's health. Read the ...

In a breakthrough cancer therapy development, scientists at MIT and Harvard Medical School created a new way of designing immune cells that could make “off-the-shelf” cancer medications more potent ...

Talking to kids about cancer can be one of the most challenging conversations a parent or caregiver will ever face. It ...

This review synthesizes the utility of exhaled volatile organic compounds (VOCs) in cancer diagnosis, treatment efficacy prediction, and recurrence monitoring. As endogenous metabolic byproducts, VOCs ...

A Nature study shows sperm from older fathers carry more disease-linked mutations, revealing how age and cell competition ...

Groundbreaking new tests reveal patterns in our immune systems that can signal underlying disease and tell us how well we ...

Scientists have discovered what goes wrong inside liver cells when alcohol-related damage can't be reversed, offering fresh ...